For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Missed opportunities over 18 months mean ovarian cancer will be fatal
Missed opportunities over 18 months mean ovarian cancer will be fatal

A patient diagnosed with stage IIB ovarian cancer reflects on her recent experience, and what lessons it holds for the doctors of the women in the future who present with this subtle disease
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
Ministry of Health (2015). Cancer: New registrations and deaths 2012. Available online
Cancer Research UK. Ovarian cancer: Survival. Available online
Ministry of Health. Ovarian cancer (pdf). Available online
Goff BA, Mandel L, Muntz HG et al. Ovarian carcinoma diagnosis: Results of a national ovarian cancer survey. Cancer 2000;89(10):2068–75.
Cancer Australia (2015). Assessment of symptoms that may be cancer: A guide for general practitioners. Available online
NICE Guidance. Ovarian cancer: recognition and initial management. CG122. April 2011. Available online